Central aortic pressure calibration: “a bridge too far”?

    loading  Checking for direct PDF access through Ovid


The article ‘Accuracy of commercial devices and methods for noninvasive estimation of aortic systolic blood pressure’ [1] and its accompanying editorial [2] give an almost exclusively European view on the subject and as perceived principally by clinicians. It contrasts with views in the United States where the Food and Drug Administration (FDA) must confirm claims for accuracy of any device before it can be marketed [3].

Related Topics

    loading  Loading Related Articles